Rodrigo Paredes de la Fuente, MD is a Resident Physician at Mount Sinai West/Morningside and a researcher at the Icahn School of Medicine at Mount Sinai. He earned his medical degree from Universidad San Martín de Porres in Lima, Peru. Following medical school, he completed a research fellowship at Beth Israel Deaconess Medical Center at Harvard Medical School in Boston, where his work focused on genomic profiling and precision oncology for pancreatic and
hepatobiliary tumors.

Rodrigo is actively involved in research within the Thoracic Oncology Department, with a particular interest in liquid biopsies and their role in guiding diagnosis and management for lung cancer patients. He has also contributed to projects advancing awareness of genomic testing and its benefits for patients.

His research has been presented at prominent conferences, including the American Society of Clinical Oncology Annual Meeting and the European Society
for Medical Oncology Congress, and he has co-authored several peer-reviewed publications. In 2024, Rodrigo was honored with the ASCO Annual Meeting
Research Award for his work on the impact of mutations in lung cancer progression and received an educational award from the International Association for the Study of Lung Cancer for his research on the impact of liquid biopsies in EGFR mutant lung cancer.

Rodrigo’s work is driven by a dedication to improving patient outcomes through cutting-edge research in precision oncology.